Creative Medical Technology Holdings announced that the U.S. Food and Drug Administration has cleared an expanded dose escalation for its ongoing Phase 1/2 trial of StemSpine usin ...

2-Year U.S. Treasury Note Continuous Contract $103.480-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $107.953 0.031 0.03% 10-Year U.S. Treasury Note Continuous Contract $111.156 0.156 ...

Here are some of the stocks that may see significant price movement today.